Results 91 to 100 of about 498 (114)

FDA-Approved Antibacterials and Echinocandins [PDF]

Since 1955, a total of 12 peptide-based drugs with antimicrobial or antifungal properties have received approval from the Food and Drug Administration (FDA).
Al Musaimi O
core  

Therapeutic compounds targeting Lipid II for antibacterial purposes

Infection and Drug Resistance, 2019
Jakob J Malin,1,2 Erik de Leeuw31University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany; 2Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 3Institute of Human ...
Malin JJ, de Leeuw E
doaj  

Commentary: Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus

Frontiers in Molecular Biosciences, 2021
Emily M. Meredith, Andrew D. Berti, Andrew D. Berti   +2 more
doaj   +1 more source

The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives [PDF]

, 2021
Andreoni, M., Bassetti, M., Corrao, S., De Rosa, F. G., Esposito, V., Falcone, M., Grossi, P., Pea, F., Petrosillo, N., Tascini, C., Venditti, M., Viale, P.   +11 more
core   +1 more source

Research News. Publications, 2017. Volume 1 [PDF]

, 2015
Publications that appeared during the period January 1 through June 30 ...
Majumdar, Soumyajit, University of Mississippi. School of Pharmacy   +1 more
core   +6 more sources

New antibiotics for bad bugs: where are we? [PDF]

core   +1 more source

Viruses as a tool in nanotechnology and target for conjugated polymers [PDF]

, 2016
Gruszka, Agnieszka
core  

Some of the next articles are maybe not open access.

Related searches:

Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

International Journal of Antimicrobial Agents, 2021
Yu-Lin Lee, Po-Yu Liu, Min-Chi Lu
exaly  

Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections

Surgical Infections, 2021
Subhashis Mitra
exaly  

Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care

Pharmacy (Basel, Switzerland), 2022
Kayla Antosz, Majdi N Al-Hasan, Julie Ann Justo   +2 more
exaly